Literature DB >> 16103531

The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes.

N S Kleiman, H D White.   

Abstract

The management of patients with acute coronary syndromes may be about to undergo a dramatic change.

Entities:  

Mesh:

Year:  2005        PMID: 16103531      PMCID: PMC1769107          DOI: 10.1136/hrt.2004.056085

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey.

Authors:  P G McGovern; D R Jacobs; E Shahar; D K Arnett; A R Folsom; H Blackburn; R V Luepker
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

Authors:  R Spacek; P Widimský; Z Straka; E Jiresová; J Dvorák; R Polásek; I Karel; R Jirmár; L Lisa; T Budesínský; F Málek; P Stanka
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

5.  An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.

Authors:  D A Morrow; E M Antman; S M Snapinn; C H McCabe; P Theroux; E Braunwald
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

6.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

Authors:  E Boersma; K S Pieper; E W Steyerberg; R G Wilcox; W C Chang; K L Lee; K M Akkerhuis; R A Harrington; J W Deckers; P W Armstrong; A M Lincoff; R M Califf; E J Topol; M L Simoons
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

7.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

8.  Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction.

Authors:  H L Dauerman; D Lessard; J Yarzebski; M I Furman; J M Gore; R J Goldberg
Journal:  Am J Cardiol       Date:  2000-10-01       Impact factor: 2.778

9.  Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.

Authors:  Thomas Aversano; Lynnet T Aversano; Eugene Passamani; Genell L Knatterud; Michael L Terrin; David O Williams; Sandra A Forman
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

10.  Cardiovascular risk factors and clinical presentation in acute coronary syndromes.

Authors:  A Rosengren; L Wallentin; M Simoons; A K Gitt; S Behar; A Battler; D Hasdai
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

View more
  2 in total

Review 1.  Identification of myocardial injury in the emergency setting.

Authors:  Peter A Kavsak; Andrew Worster; John J You; Mark Oremus; Adell Elsharif; Stephen A Hill; P J Devereaux; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Biochem       Date:  2009-12-21       Impact factor: 3.281

2.  Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event.

Authors:  Richard M Cubbon; Afroze Abbas; Stephen B Wheatcroft; Niamh Kilcullen; Raj Das; Christine Morrell; Julian H Barth; Mark T Kearney; Alistair S Hall
Journal:  PLoS One       Date:  2008-10-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.